TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS financial statements, including revenue, expenses, profit, and loss

The total revenue of 0A87 for the last quarter is 7.51 B USD, and it's 4.12% higher compared to the previous quarter. The net income of Q3 23 is 714.81 M USD.